TET2 and myeloid neoplasm: To our knowledge, a comprehensive comparison of TET2 mutations in CHIP versus myeloid malignancies has yet to be performed; however, the nature of TET2 CHIP mutations are also in keeping with TET2 catalytic inactivation.